Research
Hormonal
Tirzepatide facilitated unprecedented weight loss of up to 22.5% in non-diabetic individuals living with obesity.
This indicates that tirzepatide can be a significant option for weight management in obese individuals.
StrongSupportsmedium confidence
Remarkably, tirzepatide also facilitated unprecedented weight loss of up to 22.5% in non-diabetic individuals living with obesity.
Why this rating
The claim is based on clinical outcomes reported in the abstract.
Source
Gut hormone multi-agonists for the treatment of type 2 diabetes and obesity: advances and challenges
Xianxian Huang et al. · Journal of Endocrinology · 2024
reviewCited 16×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →